- Published at
- by gurufocus.com
neutral
neutral
3 Companies With High Quality Balance Sheets to Consider
3 Companies With High Quality Balance Sheets to Consider, Stocks: GH,ASND,TPTX, release date:Feb 10, 2021
News for Ascendis Pharma A/S (A71.MU)
- Published at
- by gurufocus.com
neutralneutral3 Companies With High Quality Balance Sheets to Consider
3 Companies With High Quality Balance Sheets to Consider, Stocks: GH,ASND,TPTX, release date:Feb 10, 2021- Published at
- by vcaonline.com
neutralneutral- Published at
- by marketscreener.com
positivepositiveVISEN Pharmaceuticals : Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients... | January 9, 2021- Published at
- by prnewswire.com
positivepositiveVISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
/PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet...- Published at
- by markets.businessinsider.com
positivepositiveVISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China
SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine dru...- Published at
- by thestreet.com
positivepositiveVISEN Pharmaceuticals Closes $150 Million Series B Financing To Accelerate The Development And Commercialization Of Its Innovative Endocrinology Therapies In Greater China
SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that- Published at
- by markets.businessinsider.com
positivepositiveVISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China
SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introduc...